|
|
|
PCG Mean |
Well Close Square |
|
CHD NSF Group + BP in last 12 months |
M+F combined |
89.6% |
92.6% |
|
CHD NSF Group + Smoking Status recorded in the last
5 years |
M+F combined |
89.8% |
97.8% |
|
CHD NSF Group Receipt of Aspirin last 12 months |
M+F combined |
93.4% |
97.3% |
|
CHD NSF Group Screened for diabetes last 12 Months |
M+F combined |
71.8% |
80.6% |
|
CHD NSF Group Cholesterol recorded last 12 months
aged <70 |
M+F combined |
82.0% |
85.4% |
|
CHD NSF Group Cholesterol < 5 last 12 months
aged <70 |
M+F combined |
39.8% |
37.0% |
|
CHD NSF Group with AF aged 60+ in receipt of Aspirin/Warfarin last
12 months |
M+F combined |
97.1% |
96.6% |
|
Hypertension + BP in last 12 months |
M+F combined |
93.8% |
92.0% |
|
Adults 15+ with BP recorded last 5 years |
M+F combined |
75.3% |
75.3% |
|
|
|
|
|
Targets 2001-2002 at end of… |
Sep-01 |
Dec-01 |
Jan-02 |
Feb-02 |
|
|
|
No of patients in NSF group |
940 |
939 |
942 |
933 |
|
|
|
NSF patients without BP record since 1/4/01 |
355 |
179 |
101 |
75 |
|
|
|
NSF patients without smoking record since 1/4/97 |
37 |
26 |
25 |
19 |
|
|
|
NSF patients without aspirin record since 1/4/01 |
362 |
206 |
154 |
132 |
|
|
|
NSF patients without diabetes |
811 |
801 |
797 |
787 |
|
|
|
NSF non-diabetics without blood glucose since 1/4/01 |
517 |
334 |
270 |
263 |
|
|
|
NSF patients under 70 years |
376 |
380 |
386 |
384 |
|
|
|
NSF patients under 70 years with no cholesterol since 1/4/01 |
189 |
124 |
87 |
61 |
|
|
|
NSF patients under 70 years with a cholesterol since 1/4/01 |
187 |
256 |
299 |
323 |
|
|
|
NSF patients under 70 years with a cholesterol result since 1/4/01 |
|
256 |
299 |
321 |
|
|
|
NSF patients under 70 years with a cholesterol >5.0 since 1/4/01 |
|
184 |
181 |
179 |
|
|
|
NSF patients under 70 years with a cholesterol <5.0 since 1/4/01 |
36 |
72 |
118 |
142 |
|
|
|
Patients with AF |
158 |
161 |
162 |
155 |
|
|
|
Patients with AF but no prophyllaxis or CI |
27 |
23 |
23 |
17 |
|
|
|
Patients with hypertension |
1331 |
1336 |
1352 |
1360 |
|
|
|
Patients with hypertension but no record of BP since 1/4/01 |
351 |
196 |
149 |
117 |
|
|
|
Patients aged over 16 |
8854 |
8825 |
8818 |
8802 |
|
|
|
Patients aged over 16 but no record of BP since 1/4/97 |
1024 |
1006 |
1015 |
1004 |
|
|
|
|
|
|
|
|
|
|
|
Targets 2001-2002 |
Sep-01 |
Dec-01 |
Jan-02 |
Feb-02 |
Target |
|
|
% NSF patients with BP record since 1/4/01 |
62% |
81% |
89% |
92% |
80% |
Pass |
|
% NSF patients with smoking record since 1/4/97 |
96% |
97% |
97% |
98% |
80% |
Pass |
|
% NSF patients with aspirin record since 1/4/01 |
61% |
78% |
84% |
86% |
80% |
Pass |
|
% NSF non-diabetics with blood glucose since 1/4/01 |
36% |
58% |
66% |
67% |
50% |
Pass |
|
% NSF patients under 70 years with cholesterol since 1/4/01 |
50% |
67% |
77% |
84% |
70% |
Pass |
|
% NSF patients under 70 years with a cholesterol <5.0 since 1/4/01 |
19% |
28% |
39% |
45% |
25% |
Pass |
|
% AF patients with prophyllaxis or CI |
83% |
86% |
86% |
89% |
60% |
Pass |
|
% Patients with hypertension with record of BP since 1/4/01 |
74% |
85% |
89% |
91% |
85% |
Pass |
|
% Patients aged over 16 with record of BP since 1/4/97 |
88% |
89% |
88% |
89% |
75% |
Pass |
|
|
|
|
|
|
|
|
|
Quinolones < 10 items per 1000 patients per year (0.8 per month) |
1.5 |
1.95 |
|
|
0.8 |
|
|
4 NSAIDs as a % of all NSAIDs |
84% |
80% |
|
|
85% |
|
|
Bendrofluazide 2.5mg as a % of all prescribed |
99% |
100% |
|
|
85% |
Pass |
|
Generic prescribing |
83% |
83% |
|
|
72% |
Pass |
|
10 antimicrobials as a % of BNF 5.1 |
89% |
88% |
|
|
85% |
Pass |
|
3 betablockers as a proportion of BNF 2.4 |
88% |
88% |
|
|
80% |
Pass |